DaVita Inc. DVA

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

DaVita has delivered a strong 87.2% share price gain over the past three years, which naturally raises a question for anyone looking at the stock today. Is the current valuation still grounded in the earnings power of the dialysis provider, or has the share price moved ahead of what the business is generating? A roughly 87.2% return over three years puts real weight on whether DaVita's earnings profile can support the price investors are paying today. The business leans on recurring...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

DaVita has underperformed the S&P 500 index over the past three months. However, Wall Street analysts are moderately optimistic about its prospects.

AllianceBernstein Global High Income Fund, Inc. [NYSE: AWF] (the "Fund") today released its monthly portfolio update as of August 31, 2026.

Paving Career Paths to Economic Mobility NORTHAMPTON, MA / ACCESS Newswire / September 14, 2026 / Sustainable career growth is about unlocking lasting economic mobility and new opportunities to learn and grow as an individual. In an evolving healthcare landscape, is working to empower teammates through intentional, comprehensive support.

NORTHAMPTON, MA / ACCESS Newswire / September 10, 2026 / 2025 marked a proud moment for as we met our goal to power 100% of our global operations with renewable energy. We achieved this by securing multiple virtual power purchase agreements in the US and Europe over the past five years - offsetting our global energy consumption with renewable solar and wind power.

DaVita’s 20.6% return over the past six months has outpaced the S&P 500 by 7%, and its stock price has climbed to $183.98 per share. This performance may have investors wondering how to approach the situation.

NORTHAMPTON, MA / ACCESS Newswire / September 8, 2026 / 's care network reaches people in every corner of the U. as well as 14 countries around the world.

NORTHAMPTON, MA / ACCESS Newswire / September 4, 2026 / At , doing the right thing and conducting business activities with the highest standards of ethics is foundational to our culture. We are firmly committed to compliance with our policies and all applicable laws and regulations.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

DaVita (DVA) is back in focus after two meaningful developments. The company expanded its value based care partnership with Humana for chronic kidney disease patients and agreed to a US$15 million settlement related to a prior data breach. Investors have been reacting to this mix of partnership news and legal resolution with a share price that is still up 58.64% year to date, despite a 30 day share price return of down 20.32%. The 3 year total shareholder return of 90.54% points to momentum...